Lemaitre Vascular Inc (LMAT)

$85.83

-0.41

(-0.48%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $84.98
    $87.55
    $85.83
    downward going graph

    0.99%

    Downside

    Day's Volatility :2.94%

    Upside

    1.96%

    downward going graph
  • $43.64
    $91.76
    $85.83
    downward going graph

    49.16%

    Downside

    52 Weeks Volatility :52.44%

    Upside

    6.46%

    downward going graph

Returns

PeriodLemaitre Vascular IncSector (Health Care)Index (Russel 2000)
3 Months
31.74%
6.5%
0.0%
6 Months
52.31%
7.1%
0.0%
1 Year
35.68%
9.8%
0.0%
3 Years
58.06%
14.2%
-20.2%

Highlights

Market Capitalization
2.0B
Book Value
$13.74
Dividend Share
0.58
Dividend Yield
0.71%
Earnings Per Share (EPS)
1.51
PE Ratio
59.83
PEG Ratio
2.77
Wall Street Target Price
83.0
Profit Margin
16.99%
Operating Margin TTM
22.2%
Return On Assets TTM
7.64%
Return On Equity TTM
11.65%
Revenue TTM
199.9M
Revenue Per Share TTM
8.97
Quarterly Revenue Growth YOY
13.600000000000001%
Gross Profit TTM
104.9M
EBITDA
50.4M
Diluted Eps TTM
1.51
Quarterly Earnings Growth YOY
0.63
EPS Estimate Current Year
1.77
EPS Estimate Next Year
1.95
EPS Estimate Current Quarter
0.39
EPS Estimate Next Quarter
0.44

Analyst Recommendation

Buy
    73%Buy
    26%Hold
    0
    0%Sell
Based on 15 Wall street analysts offering stock ratings for Lemaitre Vascular Inc(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
10
10
Hold
4
5
4
Sell
00
00
00

Analyst Forecast

What analysts predicted

Downside of 3.3%

Current $85.83
Target $83.00

Company Financials

FY18Y/Y Change
Revenue
105.6M
↑ 4.66%
Net Income
22.9M
↑ 33.57%
Net Profit Margin
21.73%
↑ 4.7%
FY19Y/Y Change
Revenue
117.2M
↑ 11.05%
Net Income
17.9M
↓ 21.83%
Net Profit Margin
15.3%
↓ 6.43%
FY20Y/Y Change
Revenue
129.4M
↑ 10.35%
Net Income
21.2M
↑ 18.32%
Net Profit Margin
16.4%
↑ 1.1%
FY21Y/Y Change
Revenue
154.4M
↑ 19.37%
Net Income
26.9M
↑ 26.8%
Net Profit Margin
17.42%
↑ 1.02%
FY22Y/Y Change
Revenue
161.7M
↑ 4.68%
Net Income
20.6M
↓ 23.31%
Net Profit Margin
12.77%
↓ 4.65%
FY23Y/Y Change
Revenue
193.5M
↑ 19.69%
Net Income
30.1M
↑ 45.89%
Net Profit Margin
15.56%
↑ 2.79%
Q4 FY22Q/Q Change
Revenue
41.0M
↑ 4.93%
Net Income
5.6M
↑ 3.13%
Net Profit Margin
13.74%
↓ 0.24%
Q1 FY23Q/Q Change
Revenue
47.1M
↑ 14.95%
Net Income
6.0M
↑ 7.34%
Net Profit Margin
12.83%
↓ 0.91%
Q2 FY23Q/Q Change
Revenue
50.1M
↑ 6.46%
Net Income
8.1M
↑ 34.07%
Net Profit Margin
16.16%
↑ 3.33%
Q3 FY23Q/Q Change
Revenue
47.4M
↓ 5.4%
Net Income
7.5M
↓ 7.36%
Net Profit Margin
15.82%
↓ 0.34%
Q4 FY23Q/Q Change
Revenue
48.9M
↑ 3.1%
Net Income
8.5M
↑ 12.84%
Net Profit Margin
17.32%
↑ 1.5%
Q1 FY24Q/Q Change
Revenue
53.5M
↑ 9.4%
Net Income
9.9M
↑ 16.8%
Net Profit Margin
18.49%
↑ 1.17%
FY18Y/Y Change
Total Assets
153.1M
↑ 21.19%
Total Liabilities
22.9M
↑ 38.06%
FY19Y/Y Change
Total Assets
188.3M
↑ 23.03%
Total Liabilities
40.2M
↑ 75.89%
FY20Y/Y Change
Total Assets
252.8M
↑ 34.23%
Total Liabilities
80.2M
↑ 99.62%
FY21Y/Y Change
Total Assets
292.8M
↑ 15.82%
Total Liabilities
38.7M
↓ 51.83%
FY22Y/Y Change
Total Assets
310.5M
↑ 6.04%
Total Liabilities
42.3M
↑ 9.38%
FY23Y/Y Change
Total Assets
346.8M
↑ 11.69%
Total Liabilities
48.9M
↑ 15.62%
Q4 FY22Q/Q Change
Total Assets
310.5M
↑ 2.79%
Total Liabilities
42.3M
↑ 3.61%
Q1 FY23Q/Q Change
Total Assets
314.9M
↑ 1.41%
Total Liabilities
40.7M
↓ 3.72%
Q2 FY23Q/Q Change
Total Assets
326.5M
↑ 3.68%
Total Liabilities
42.6M
↑ 4.76%
Q3 FY23Q/Q Change
Total Assets
334.0M
↑ 2.31%
Total Liabilities
45.4M
↑ 6.41%
Q4 FY23Q/Q Change
Total Assets
346.8M
↑ 3.82%
Total Liabilities
48.9M
↑ 7.72%
Q1 FY24Q/Q Change
Total Assets
354.0M
↑ 2.07%
Total Liabilities
45.5M
↓ 7.01%
FY18Y/Y Change
Operating Cash Flow
19.5M
↓ 14.7%
Investing Cash Flow
-7.1M
↓ 75.64%
Financing Cash Flow
-4.4M
↓ 5620.0%
FY19Y/Y Change
Operating Cash Flow
14.2M
↓ 27.31%
Investing Cash Flow
-24.1M
↑ 241.6%
Financing Cash Flow
-4.6M
↑ 4.66%
FY20Y/Y Change
Operating Cash Flow
34.8M
↑ 145.43%
Investing Cash Flow
-52.9M
↑ 119.46%
Financing Cash Flow
32.2M
↓ 795.69%
FY21Y/Y Change
Operating Cash Flow
35.1M
↑ 0.87%
Investing Cash Flow
-61.1M
↑ 15.48%
Financing Cash Flow
13.7M
↓ 57.39%
FY22Y/Y Change
Operating Cash Flow
25.4M
↓ 27.7%
Investing Cash Flow
-10.4M
↓ 83.02%
Financing Cash Flow
-9.2M
↓ 167.39%
Q4 FY22Q/Q Change
Operating Cash Flow
4.1M
↓ 44.47%
Investing Cash Flow
-402.0K
↓ 95.25%
Financing Cash Flow
-2.1M
↓ 1.16%
Q1 FY23Q/Q Change
Operating Cash Flow
2.3M
↓ 44.1%
Investing Cash Flow
-3.0M
↑ 637.31%
Financing Cash Flow
-1.8M
↓ 14.0%
Q2 FY23Q/Q Change
Operating Cash Flow
11.9M
↑ 422.29%
Investing Cash Flow
-9.6M
↑ 225.2%
Financing Cash Flow
502.0K
↓ 127.51%

Technicals Summary

Sell

Neutral

Buy

Lemaitre Vascular Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lemaitre Vascular Inc
Lemaitre Vascular Inc
5.31%
52.31%
35.68%
58.06%
164.54%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
-1.32%
16.54%
32.6%
35.62%
148.32%
Resmed Inc.
Resmed Inc.
11.69%
9.57%
-6.0%
-19.79%
64.22%
Becton, Dickinson And Company
Becton, Dickinson And Company
0.5%
-1.64%
-17.69%
-6.68%
-8.49%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-14.37%
-23.3%
-26.95%
-26.58%
102.44%
Alcon Ag
Alcon Ag
2.41%
20.84%
8.21%
30.7%
54.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lemaitre Vascular Inc
Lemaitre Vascular Inc
59.83
59.83
2.77
1.77
0.12
0.08
0.01
13.74
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
78.14
78.14
7.13
6.63
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
32.24
32.24
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
50.71
50.71
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.71
42.71
6.72
7.74
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
44.05
44.05
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lemaitre Vascular Inc
Lemaitre Vascular Inc
Buy
$2.0B
164.54%
59.83
16.99%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$161.3B
148.32%
78.14
27.65%
Resmed Inc.
Resmed Inc.
Buy
$30.8B
64.22%
32.24
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$68.6B
-8.49%
50.71
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.7B
102.44%
42.71
19.42%
Alcon Ag
Alcon Ag
Buy
$45.8B
54.72%
44.05
10.96%

Insights on Lemaitre Vascular Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 47.41M → 53.47M (in $), with an average increase of 5.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 7.50M → 9.88M (in $), with an average increase of 12.9% per quarter

Institutional Holdings

  • BlackRock Inc

    14.94%

  • Conestoga Capital Advisors, LLC

    8.61%

  • Vanguard Group Inc

    6.92%

  • Copeland Capital Management, LLC

    5.75%

  • Geneva Capital Management

    4.01%

  • Ranger Investment Management LP

    3.67%

Corporate Announcements

  • Lemaitre Vascular Inc Dividends March,2024

    In the quarter ending March,2024. Lemaitre Vascular Inc has declared dividend of $0.16

    Read More

Company Information

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.

Organization
Lemaitre Vascular Inc
Employees
614
CEO
Mr. George W. LeMaitre
Industry
Health Technology

Discover More

FAQs